Global Vaccines Market Growth 2024-2030
Vaccines market, valued at US$44.30 billion in 2023, anticipated to reach US$65.77 billion by 2030, driven by increasing demand in downstream sectors with a 5.8% CAGR.
- Bonafide Trust
- 04-01-2024
- Pages : 111
- Figures : 95
- Tables : 149
- Region : Global
- Category : Lifescience
- Pharmaceutical
According to publisher, the global Vaccines market size was valued at US$ 44300 million in 2023. With growing demand in downstream market, the Vaccines is forecast to a readjusted size of US$ 65770 million by 2030 with a CAGR of 5.8% during review period.
The research report highlights the growth potential of the global Vaccines market. Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Vaccines market.
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and ""remember"" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
The major players in global Vaccines market include Merck, GSK, Sanofi, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 65% of the global market. Recombinant Vaccines is the main type, with a share about 35%. Rabies vaccine, Influenza vaccine, HPV vaccine are main applications, which hold a share about 35%.
Key Features:
The report on Vaccines market reflects various aspects and provide valuable insights into the industry. The worldwide antibodies advertise plays a crucial part in securing populaces from irresistible illnesses.
Market Measure and Development Trajectory
The worldwide antibodies advertise measure is assessed to be around USD 74.80 billion in 2023 and is anticipated to reach USD 168.69 billion by 2031, reflecting a noteworthy CAGR of 10.7. This implies a relentless extension driven by a few key factors.
Key Development Drivers
Rising Centre on Immunization Programs Governments around the world are prioritizing childhood immunization programs and growing immunization scope for grown-ups. This guarantees broader security against preventable maladies. For occasion, the World Wellbeing Organization WHO has set driven objectives to attain tall national immunization scope rates for different childhood vaccines. Emerging Irresistible Infections The development of modern irresistible illnesses and episodes, like COVID 19, highlight the significance of antibody advancement and fast reaction capabilities. This fills speculation in investigate and improvement of novel vaccines. Technological Progressions in antibody innovation, such as mRNA immunizations and viral vector antibodies, are driving to the improvement of more compelling and focused on antibodies. The victory of mRNA antibodies against COVID 19 grandstands the potential of these unused technologies. Growing Geriatric Populace, The rising worldwide populace matured 65 and over increments the request for immunizations against illnesses like pneumonia and shingles, which can be especially extreme in more seasoned adults.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download SampleChallenges and Opportunities:
Vaccine Reluctance and Deception Combating antibody aversion and tending to deception encompassing antibodies is pivotal to guarantee tall inoculation rates. Instructive campaigns and community engagement are fundamental to advance antibody confidence. Vaccine Value and Openness Guaranteeing evenhanded access to antibodies all-inclusive remains a challenge. Activities like COVAX, co led by WHO, point to supply impartial get to to COVID 19 antibodies for moo and middle-income countries. Supply Chain Challenges: Keeping up vigorous and effective supply chains for antibody generation and dissemination is basic, particularly amid pandemics. The COVID 19 pandemic highlighted the require for expansion and strength in antibody supply chains.
Future Outlook:
The worldwide immunizations advertise is anticipated to witness proceeded development due to Continuous Require for Childhood Immunizations Schedule childhood immunization programs will stay a consistent driver for the market. Focus on Widespread Readiness Contributing in inquire about and advancement of immunizations for potential future pandemics will be a priority. Advancements in Immunization Innovation The progressing advancement of unused antibody stages and conveyance strategies holds guarantee for more compelling and open antibodies.
Market Size and Growth: The research report provide an overview of the current size and growth of the Vaccines market. It may include historical data, market segmentation by Type (e.g., Recombinant Vaccines, Viral Vaccines), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Vaccines industry. This include advancements in Vaccines technology, Vaccines new entrants, Vaccines new investment, and other innovations that are shaping the future of Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Vaccines market.
Market Segmentation:
Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others
Segmentation by application
Rabies vaccine
Influenza vaccine
HPV vaccine
Hepatitis B
Hepatitis A
Leprosy vaccine
Polio vaccine
JE vaccine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GSK
Sanofi
Merck
Pfizer
Novartis(GSK)
CSL
MedImmune LLC
J&J(Crucell)
China National Biotec
Tiantan
Hualan
Kangtai
Hissen
Jintan
Table of Contents
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Vaccines Annual Sales 2019-2030
- 2.1.2 World Current & Future Analysis for Vaccines by Geographic Region, 2019, 2023 & 2030
- 2.1.3 World Current & Future Analysis for Vaccines by Country/Region, 2019, 2023 & 2030
- 2.2 Vaccines Segment by Type
- 2.2.1 Recombinant Vaccines
- 2.2.2 Viral Vaccines
- 2.2.3 Polysaccharide Vaccines
- 2.2.4 Others
- 2.3 Vaccines Sales by Type
- 2.3.1 Global Vaccines Sales Market Share by Type (2019-2024)
- 2.3.2 Global Vaccines Revenue and Market Share by Type (2019-2024)
- 2.3.3 Global Vaccines Sale Price by Type (2019-2024)
- 2.4 Vaccines Segment by Application
- 2.4.1 Rabies vaccine
- 2.4.2 Influenza vaccine
- 2.4.3 HPV vaccine
- 2.4.4 Hepatitis B
- 2.4.5 Hepatitis A
- 2.4.6 Leprosy vaccine
- 2.4.7 Polio vaccine
- 2.4.8 JE vaccine
- 2.4.9 Others
- 2.5 Vaccines Sales by Application
- 2.5.1 Global Vaccines Sale Market Share by Application (2019-2024)
- 2.5.2 Global Vaccines Revenue and Market Share by Application (2019-2024)
- 2.5.3 Global Vaccines Sale Price by Application (2019-2024)
- 3 Global Vaccines by Company
- 3.1 Global Vaccines Breakdown Data by Company
- 3.1.1 Global Vaccines Annual Sales by Company (2019-2024)
- 3.1.2 Global Vaccines Sales Market Share by Company (2019-2024)
- 3.2 Global Vaccines Annual Revenue by Company (2019-2024)
- 3.2.1 Global Vaccines Revenue by Company (2019-2024)
- 3.2.2 Global Vaccines Revenue Market Share by Company (2019-2024)
- 3.3 Global Vaccines Sale Price by Company
- 3.4 Key Manufacturers Vaccines Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Vaccines Product Location Distribution
- 3.4.2 Players Vaccines Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
- 4 World Historic Review for Vaccines by Geographic Region
- 4.1 World Historic Vaccines Market Size by Geographic Region (2019-2024)
- 4.1.1 Global Vaccines Annual Sales by Geographic Region (2019-2024)
- 4.1.2 Global Vaccines Annual Revenue by Geographic Region (2019-2024)
- 4.2 World Historic Vaccines Market Size by Country/Region (2019-2024)
- 4.2.1 Global Vaccines Annual Sales by Country/Region (2019-2024)
- 4.2.2 Global Vaccines Annual Revenue by Country/Region (2019-2024)
- 4.3 Americas Vaccines Sales Growth
- 4.4 APAC Vaccines Sales Growth
- 4.5 Europe Vaccines Sales Growth
- 4.6 Middle East & Africa Vaccines Sales Growth
- 5 Americas
- 5.1 Americas Vaccines Sales by Country
- 5.1.1 Americas Vaccines Sales by Country (2019-2024)
- 5.1.2 Americas Vaccines Revenue by Country (2019-2024)
- 5.2 Americas Vaccines Sales by Type
- 5.3 Americas Vaccines Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Vaccines Sales by Region
- 6.1.1 APAC Vaccines Sales by Region (2019-2024)
- 6.1.2 APAC Vaccines Revenue by Region (2019-2024)
- 6.2 APAC Vaccines Sales by Type
- 6.3 APAC Vaccines Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe Vaccines by Country
- 7.1.1 Europe Vaccines Sales by Country (2019-2024)
- 7.1.2 Europe Vaccines Revenue by Country (2019-2024)
- 7.2 Europe Vaccines Sales by Type
- 7.3 Europe Vaccines Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Vaccines by Country
- 8.1.1 Middle East & Africa Vaccines Sales by Country (2019-2024)
- 8.1.2 Middle East & Africa Vaccines Revenue by Country (2019-2024)
- 8.2 Middle East & Africa Vaccines Sales by Type
- 8.3 Middle East & Africa Vaccines Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Vaccines
- 10.3 Manufacturing Process Analysis of Vaccines
- 10.4 Industry Chain Structure of Vaccines
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Vaccines Distributors
- 11.3 Vaccines Customer
- 12 World Forecast Review for Vaccines by Geographic Region
- 12.1 Global Vaccines Market Size Forecast by Region
- 12.1.1 Global Vaccines Forecast by Region (2025-2030)
- 12.1.2 Global Vaccines Annual Revenue Forecast by Region (2025-2030)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Vaccines Forecast by Type
- 12.7 Global Vaccines Forecast by Application
- 13 Key Players Analysis
- 13.1 GSK
- 13.1.1 GSK Company Information
- 13.1.2 GSK Vaccines Product Portfolios and Specifications
- 13.1.3 GSK Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.1.4 GSK Main Business Overview
- 13.1.5 GSK Latest Developments
- 13.2 Sanofi
- 13.2.1 Sanofi Company Information
- 13.2.2 Sanofi Vaccines Product Portfolios and Specifications
- 13.2.3 Sanofi Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.2.4 Sanofi Main Business Overview
- 13.2.5 Sanofi Latest Developments
- 13.3 Merck
- 13.3.1 Merck Company Information
- 13.3.2 Merck Vaccines Product Portfolios and Specifications
- 13.3.3 Merck Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.3.4 Merck Main Business Overview
- 13.3.5 Merck Latest Developments
- 13.4 Pfizer
- 13.4.1 Pfizer Company Information
- 13.4.2 Pfizer Vaccines Product Portfolios and Specifications
- 13.4.3 Pfizer Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.4.4 Pfizer Main Business Overview
- 13.4.5 Pfizer Latest Developments
- 13.5 Novartis(GSK)
- 13.5.1 Novartis(GSK) Company Information
- 13.5.2 Novartis(GSK) Vaccines Product Portfolios and Specifications
- 13.5.3 Novartis(GSK) Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.5.4 Novartis(GSK) Main Business Overview
- 13.5.5 Novartis(GSK) Latest Developments
- 13.6 CSL
- 13.6.1 CSL Company Information
- 13.6.2 CSL Vaccines Product Portfolios and Specifications
- 13.6.3 CSL Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.6.4 CSL Main Business Overview
- 13.6.5 CSL Latest Developments
- 13.7 MedImmune LLC
- 13.7.1 MedImmune LLC Company Information
- 13.7.2 MedImmune LLC Vaccines Product Portfolios and Specifications
- 13.7.3 MedImmune LLC Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.7.4 MedImmune LLC Main Business Overview
- 13.7.5 MedImmune LLC Latest Developments
- 13.8 J&J(Crucell)
- 13.8.1 J&J(Crucell) Company Information
- 13.8.2 J&J(Crucell) Vaccines Product Portfolios and Specifications
- 13.8.3 J&J(Crucell) Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.8.4 J&J(Crucell) Main Business Overview
- 13.8.5 J&J(Crucell) Latest Developments
- 13.9 China National Biotec
- 13.9.1 China National Biotec Company Information
- 13.9.2 China National Biotec Vaccines Product Portfolios and Specifications
- 13.9.3 China National Biotec Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.9.4 China National Biotec Main Business Overview
- 13.9.5 China National Biotec Latest Developments
- 13.10 Tiantan
- 13.10.1 Tiantan Company Information
- 13.10.2 Tiantan Vaccines Product Portfolios and Specifications
- 13.10.3 Tiantan Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.10.4 Tiantan Main Business Overview
- 13.10.5 Tiantan Latest Developments
- 13.11 Hualan
- 13.11.1 Hualan Company Information
- 13.11.2 Hualan Vaccines Product Portfolios and Specifications
- 13.11.3 Hualan Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.11.4 Hualan Main Business Overview
- 13.11.5 Hualan Latest Developments
- 13.12 Kangtai
- 13.12.1 Kangtai Company Information
- 13.12.2 Kangtai Vaccines Product Portfolios and Specifications
- 13.12.3 Kangtai Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.12.4 Kangtai Main Business Overview
- 13.12.5 Kangtai Latest Developments
- 13.13 Hissen
- 13.13.1 Hissen Company Information
- 13.13.2 Hissen Vaccines Product Portfolios and Specifications
- 13.13.3 Hissen Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.13.4 Hissen Main Business Overview
- 13.13.5 Hissen Latest Developments
- 13.14 Jintan
- 13.14.1 Jintan Company Information
- 13.14.2 Jintan Vaccines Product Portfolios and Specifications
- 13.14.3 Jintan Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
- 13.14.4 Jintan Main Business Overview
- 13.14.5 Jintan Latest Developments
- 14 Research Findings and Conclusion
List of Tables
Table 1. Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Vaccines Sales by Type (2019-2024) & (K Units)
Table 8. Global Vaccines Sales Market Share by Type (2019-2024)
Table 9. Global Vaccines Revenue by Type (2019-2024) & ($ million)
Table 10. Global Vaccines Revenue Market Share by Type (2019-2024)
Table 11. Global Vaccines Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Vaccines Sales by Application (2019-2024) & (K Units)
Table 13. Global Vaccines Sales Market Share by Application (2019-2024)
Table 14. Global Vaccines Revenue by Application (2019-2024)
Table 15. Global Vaccines Revenue Market Share by Application (2019-2024)
Table 16. Global Vaccines Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Vaccines Sales by Company (2019-2024) & (K Units)
Table 18. Global Vaccines Sales Market Share by Company (2019-2024)
Table 19. Global Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Vaccines Revenue Market Share by Company (2019-2024)
Table 21. Global Vaccines Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Vaccines Producing Area Distribution and Sales Area
Table 23. Players Vaccines Products Offered
Table 24. Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Vaccines Sales Market Share Geographic Region (2019-2024)
Table 29. Global Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Vaccines Sales Market Share by Country/Region (2019-2024)
Table 33. Global Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Vaccines Sales by Country (2019-2024) & (K Units)
Table 36. Americas Vaccines Sales Market Share by Country (2019-2024)
Table 37. Americas Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Vaccines Revenue Market Share by Country (2019-2024)
Table 39. Americas Vaccines Sales by Type (2019-2024) & (K Units)
Table 40. Americas Vaccines Sales by Application (2019-2024) & (K Units)
Table 41. APAC Vaccines Sales by Region (2019-2024) & (K Units)
Table 42. APAC Vaccines Sales Market Share by Region (2019-2024)
Table 43. APAC Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Vaccines Revenue Market Share by Region (2019-2024)
Table 45. APAC Vaccines Sales by Type (2019-2024) & (K Units)
Table 46. APAC Vaccines Sales by Application (2019-2024) & (K Units)
Table 47. Europe Vaccines Sales by Country (2019-2024) & (K Units)
Table 48. Europe Vaccines Sales Market Share by Country (2019-2024)
Table 49. Europe Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Vaccines Revenue Market Share by Country (2019-2024)
Table 51. Europe Vaccines Sales by Type (2019-2024) & (K Units)
Table 52. Europe Vaccines Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Vaccines Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Vaccines Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Vaccines Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Vaccines Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Vaccines Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Vaccines
Table 60. Key Market Challenges & Risks of Vaccines
Table 61. Key Industry Trends of Vaccines
Table 62. Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Vaccines Distributors List
Table 65. Vaccines Customer List
Table 66. Global Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. GSK Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK Vaccines Product Portfolios and Specifications
Table 82. GSK Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Sanofi Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Vaccines Product Portfolios and Specifications
Table 87. Sanofi Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Merck Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Vaccines Product Portfolios and Specifications
Table 92. Merck Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Pfizer Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Vaccines Product Portfolios and Specifications
Table 97. Pfizer Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Novartis(GSK) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis(GSK) Vaccines Product Portfolios and Specifications
Table 102. Novartis(GSK) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Novartis(GSK) Main Business
Table 104. Novartis(GSK) Latest Developments
Table 105. CSL Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. CSL Vaccines Product Portfolios and Specifications
Table 107. CSL Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. CSL Main Business
Table 109. CSL Latest Developments
Table 110. MedImmune LLC Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. MedImmune LLC Vaccines Product Portfolios and Specifications
Table 112. MedImmune LLC Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. MedImmune LLC Main Business
Table 114. MedImmune LLC Latest Developments
Table 115. J&J(Crucell) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. J&J(Crucell) Vaccines Product Portfolios and Specifications
Table 117. J&J(Crucell) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. J&J(Crucell) Main Business
Table 119. J&J(Crucell) Latest Developments
Table 120. China National Biotec Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. China National Biotec Vaccines Product Portfolios and Specifications
Table 122. China National Biotec Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. China National Biotec Main Business
Table 124. China National Biotec Latest Developments
Table 125. Tiantan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Tiantan Vaccines Product Portfolios and Specifications
Table 127. Tiantan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Tiantan Main Business
Table 129. Tiantan Latest Developments
Table 130. Hualan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Vaccines Product Portfolios and Specifications
Table 132. Hualan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Main Business
Table 134. Hualan Latest Developments
Table 135. Kangtai Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Kangtai Vaccines Product Portfolios and Specifications
Table 137. Kangtai Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kangtai Main Business
Table 139. Kangtai Latest Developments
Table 140. Hissen Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. Hissen Vaccines Product Portfolios and Specifications
Table 142. Hissen Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Hissen Main Business
Table 144. Hissen Latest Developments
Table 145. Jintan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 146. Jintan Vaccines Product Portfolios and Specifications
Table 147. Jintan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Jintan Main Business
Table 149. Jintan Latest Developments
Table 1. Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Vaccines Sales by Type (2019-2024) & (K Units)
Table 8. Global Vaccines Sales Market Share by Type (2019-2024)
Table 9. Global Vaccines Revenue by Type (2019-2024) & ($ million)
Table 10. Global Vaccines Revenue Market Share by Type (2019-2024)
Table 11. Global Vaccines Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Vaccines Sales by Application (2019-2024) & (K Units)
Table 13. Global Vaccines Sales Market Share by Application (2019-2024)
Table 14. Global Vaccines Revenue by Application (2019-2024)
Table 15. Global Vaccines Revenue Market Share by Application (2019-2024)
Table 16. Global Vaccines Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Vaccines Sales by Company (2019-2024) & (K Units)
Table 18. Global Vaccines Sales Market Share by Company (2019-2024)
Table 19. Global Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Vaccines Revenue Market Share by Company (2019-2024)
Table 21. Global Vaccines Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Vaccines Producing Area Distribution and Sales Area
Table 23. Players Vaccines Products Offered
Table 24. Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Vaccines Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Vaccines Sales Market Share Geographic Region (2019-2024)
Table 29. Global Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Vaccines Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Vaccines Sales Market Share by Country/Region (2019-2024)
Table 33. Global Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Vaccines Sales by Country (2019-2024) & (K Units)
Table 36. Americas Vaccines Sales Market Share by Country (2019-2024)
Table 37. Americas Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Vaccines Revenue Market Share by Country (2019-2024)
Table 39. Americas Vaccines Sales by Type (2019-2024) & (K Units)
Table 40. Americas Vaccines Sales by Application (2019-2024) & (K Units)
Table 41. APAC Vaccines Sales by Region (2019-2024) & (K Units)
Table 42. APAC Vaccines Sales Market Share by Region (2019-2024)
Table 43. APAC Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Vaccines Revenue Market Share by Region (2019-2024)
Table 45. APAC Vaccines Sales by Type (2019-2024) & (K Units)
Table 46. APAC Vaccines Sales by Application (2019-2024) & (K Units)
Table 47. Europe Vaccines Sales by Country (2019-2024) & (K Units)
Table 48. Europe Vaccines Sales Market Share by Country (2019-2024)
Table 49. Europe Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Vaccines Revenue Market Share by Country (2019-2024)
Table 51. Europe Vaccines Sales by Type (2019-2024) & (K Units)
Table 52. Europe Vaccines Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Vaccines Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Vaccines Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Vaccines Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Vaccines Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Vaccines Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Vaccines
Table 60. Key Market Challenges & Risks of Vaccines
Table 61. Key Industry Trends of Vaccines
Table 62. Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Vaccines Distributors List
Table 65. Vaccines Customer List
Table 66. Global Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Vaccines Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Vaccines Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Vaccines Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Vaccines Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. GSK Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK Vaccines Product Portfolios and Specifications
Table 82. GSK Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Sanofi Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Vaccines Product Portfolios and Specifications
Table 87. Sanofi Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Merck Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Vaccines Product Portfolios and Specifications
Table 92. Merck Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Pfizer Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Vaccines Product Portfolios and Specifications
Table 97. Pfizer Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Novartis(GSK) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis(GSK) Vaccines Product Portfolios and Specifications
Table 102. Novartis(GSK) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Novartis(GSK) Main Business
Table 104. Novartis(GSK) Latest Developments
Table 105. CSL Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. CSL Vaccines Product Portfolios and Specifications
Table 107. CSL Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. CSL Main Business
Table 109. CSL Latest Developments
Table 110. MedImmune LLC Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. MedImmune LLC Vaccines Product Portfolios and Specifications
Table 112. MedImmune LLC Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. MedImmune LLC Main Business
Table 114. MedImmune LLC Latest Developments
Table 115. J&J(Crucell) Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. J&J(Crucell) Vaccines Product Portfolios and Specifications
Table 117. J&J(Crucell) Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. J&J(Crucell) Main Business
Table 119. J&J(Crucell) Latest Developments
Table 120. China National Biotec Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. China National Biotec Vaccines Product Portfolios and Specifications
Table 122. China National Biotec Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. China National Biotec Main Business
Table 124. China National Biotec Latest Developments
Table 125. Tiantan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Tiantan Vaccines Product Portfolios and Specifications
Table 127. Tiantan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Tiantan Main Business
Table 129. Tiantan Latest Developments
Table 130. Hualan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Vaccines Product Portfolios and Specifications
Table 132. Hualan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Hualan Main Business
Table 134. Hualan Latest Developments
Table 135. Kangtai Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Kangtai Vaccines Product Portfolios and Specifications
Table 137. Kangtai Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Kangtai Main Business
Table 139. Kangtai Latest Developments
Table 140. Hissen Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. Hissen Vaccines Product Portfolios and Specifications
Table 142. Hissen Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Hissen Main Business
Table 144. Hissen Latest Developments
Table 145. Jintan Basic Information, Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 146. Jintan Vaccines Product Portfolios and Specifications
Table 147. Jintan Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Jintan Main Business
Table 149. Jintan Latest Developments
Related Reports
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. Read More
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. Read More
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. Read More
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). Read More
Safe and Secure SSL Encrypted
Quick Contacts
Want to customize this report?
We offer 10% Free Customization at the time of purchase
Get Free Customization
Trusted Partners
Budget constraints? Get in touch with us for special pricing
Request DiscountOrder Detail
- Order Placed (14 December, 2024)
- Notify To Team (14 December, 2024)
- Report updation (15 December, 2024)
- Report Quality Check (15 December, 2024)
- Report Dispatch (16 December, 2024)
- Hard Copy
Recently Viewed Products
Global Vaccines Market Growth 2024-2030
We are friendly and approachable, give us a call.